EUVIMEDEUVIMED entdecken
Crossref

Chitosan coated multifunctional NiFe₂O₄ nanocomposites as a promising candidate for biomedical applications

Indumathi Thangavelu, Srinivas Tadepalli

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04904-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Indumathi Thangavelu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, CHRIST (Deemed to Be University), Bangalore, 560029, India. Hauptthemen laut MEDLINE: Chitosan, Nanocomposites, Antineoplastic Agents, Ferric Compounds. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles for biomedical applications often suffer from limited stability, low biocompatibility, and suboptimal therapeutic efficacy. To address these challenges, NiFe₂O₄ nanoparticles were functionalized with chitosan (NiFe₂O₄-CS) via a co-precipitation method, aiming to enhance their structural, optical, antimicrobial, and anticancer properties. XRD analysis revealed a reduction in crystallite size from 37 to 33 nm after chitosan modification, indicating controlled crystal growth and increased surface area. TEM results confirmed a corresponding decrease in particle size from 35 ± 2.1 nm to 29 ± 1.8 nm, improving surface reactivity and stability. PL spectra exhibited a red-shift in green emission peaks, suggesting increased oxygen vacancies and defect states that facilitate ROS generation. Antimicrobial assays against methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans (C.albicans) demonstrated significantly higher activity for NiFe₂O₄-CS nanocomposites, supported by SEM imaging that showed extensive microbial membrane disruption. Furthermore, NiFe₂O₄-CS exhibited enhanced anticancer activity against C6 glioma cells, with an IC₅₀ of 35.6 µg/mL compared to 43.6 µg/mL for unmodified nanoparticles. Zebrafish embryo studies confirmed the biocompatibility of NiFe₂O₄-CS at appropriate doses, although dose-dependent embryotoxicity was observed. These findings highlight that chitosan functionalization of dual-metal nanoparticles improves therapeutic efficacy through increased surface interactions and ROS generation while underscoring the need for careful dose optimization. This study presents a novel strategy for designing biopolymer-coated nanocomposites that balance enhanced biomedical performance with safety considerations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanNanocompositesAntineoplastic AgentsFerric CompoundsAnti-Infective AgentsAnimalsZebrafishCandida albicansMethicillin-Resistant Staphylococcus aureusCell Line, TumorParticle SizeEmbryo, NonmammalianGliomaReactive Oxygen SpeciesMicrobial Sensitivity TestsNickel

Stichwörter der Autor:innen

BiocompatibilityEmbryotoxicGlioma cancerMRSANiFe2O4Zebrafish

Substanzen

ChitosanAntineoplastic AgentsFerric Compoundsnickel ferriteReactive Oxygen SpeciesAnti-Infective AgentsNickel

Autor:innen und Institutionen

  • Department of Chemistry, CHRIST (Deemed to Be University), Bangalore, 560029, India.
  • Department of Chemical Engineering, College of Engineering, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11432, Riyadh, Kingdom of Saudi Arabia. stadepalli@imamu.edu.sa.

Zitieren

APA

Thangavelu, I., & Tadepalli, S. (2026). Chitosan coated multifunctional NiFe₂O₄ nanocomposites as a promising candidate for biomedical applications. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04904-3

Vancouver

Thangavelu I, Tadepalli S. Chitosan coated multifunctional NiFe₂O₄ nanocomposites as a promising candidate for biomedical applications. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04904-3

BibTeX
@article{Thangavelu2026,
  author = {Thangavelu, Indumathi and Tadepalli, Srinivas},
  title = {Chitosan coated multifunctional NiFe₂O₄ nanocomposites as a promising candidate for biomedical applications},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04904-3}
}
Kostenlos starten →